These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 1538276)
21. Detection of epidermal growth factor receptor and human epidermal growth factor receptor 2 activating mutations in lung adenocarcinoma by high-resolution melting amplicon analysis: correlation with gene copy number, protein expression, and hormone receptor expression. Willmore-Payne C; Holden JA; Layfield LJ Hum Pathol; 2006 Jun; 37(6):755-63. PubMed ID: 16733218 [TBL] [Abstract][Full Text] [Related]
22. EGFR alterations in pancreatic ductal adenocarcinoma: a chromogenic in situ hybridization analysis based on tissue microarrays. Tsiambas E; Karameris A; Lazaris AC; Talieri M; Triantafillidis JK; Cheracakis P; Manaios L; Gerontopoulos K; Patsouris E; Lygidakis NJ Hepatogastroenterology; 2006; 53(69):452-7. PubMed ID: 16795991 [TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical expression of transforming growth factor alpha and epidermal growth factor receptor in pancreatic endocrine tumors. Srivastava A; Alexander J; Lomakin I; Dayal Y Hum Pathol; 2001 Nov; 32(11):1184-9. PubMed ID: 11727256 [TBL] [Abstract][Full Text] [Related]
24. Clinicopathological significance of epidermal growth factor and its receptor in human pancreatic cancer. Uegaki K; Nio Y; Inoue Y; Minari Y; Sato Y; Song MM; Dong M; Tamura K Anticancer Res; 1997; 17(5B):3841-7. PubMed ID: 9427790 [TBL] [Abstract][Full Text] [Related]
25. Expression of EGF, TGF-alpha, EGFR and c-erbB2 genes and their gene products in human pancreatic carcinoma cell lines. Chen J; Liu TH Zentralbl Pathol; 1994 Aug; 140(3):265-70. PubMed ID: 7947634 [TBL] [Abstract][Full Text] [Related]
26. The epidermal growth factor receptor in glioblastoma: genomic amplification, protein expression, and patient survival data in a therapeutic trial. Schober R; Bilzer T; Waha A; Reifenberger G; Wechsler W; von Deimling A; Wiestler OD; Westphal M; Kemshead JT; Vega F Clin Neuropathol; 1995; 14(3):169-74. PubMed ID: 7671460 [TBL] [Abstract][Full Text] [Related]
27. Complex post-transcriptional regulation of EGF-receptor expression by EGF and TGF-alpha in human prostate cancer cells. Seth D; Shaw K; Jazayeri J; Leedman PJ Br J Cancer; 1999 May; 80(5-6):657-69. PubMed ID: 10360641 [TBL] [Abstract][Full Text] [Related]
28. Role of epidermal growth factor receptor and STAT-3 activation in autonomous proliferation of SUM-102PT human breast cancer cells. Sartor CI; Dziubinski ML; Yu CL; Jove R; Ethier SP Cancer Res; 1997 Mar; 57(5):978-87. PubMed ID: 9041204 [TBL] [Abstract][Full Text] [Related]
29. Expression of epithelial growth factor receptor and its two ligands, transforming growth factor-alpha and epithelial growth factor, in normal and neoplastic squamous cells in the vulva: an immunohistochemical study. Wu X; Xin Y; Yao J; Hasui K; Tsuyama S; Yonezawa S; Murata F Med Electron Microsc; 2001 Sep; 34(3):179-84. PubMed ID: 11793194 [TBL] [Abstract][Full Text] [Related]
30. Expression of transforming growth factor alpha and epidermal growth factor receptor in rat lung neoplasms induced by plutonium-239. Stegelmeier BL; Gillett NA; Hahn FF; Rebar AH; Kelly G Radiat Res; 1994 Nov; 140(2):191-8. PubMed ID: 7938468 [TBL] [Abstract][Full Text] [Related]
31. Enhanced erbB-3 expression in human pancreatic cancer correlates with tumor progression. Friess H; Yamanaka Y; Kobrin MS; Do DA; Büchler MW; Korc M Clin Cancer Res; 1995 Nov; 1(11):1413-20. PubMed ID: 9815939 [TBL] [Abstract][Full Text] [Related]
32. The prognostic significance of epidermal growth factor receptor (EGFR), C-erbB-2, Ki-67 and PCNA expression in breast cancer. Ioachim E; Kamina S; Athanassiadou S; Agnantis NJ Anticancer Res; 1996; 16(5B):3141-7. PubMed ID: 8920782 [TBL] [Abstract][Full Text] [Related]
33. Epidermal growth factor receptor (EGFR) expression in prostatic adenocarcinoma after hormonal therapy: a fluorescence in situ hybridization and immunohistochemical analysis. Marks RA; Zhang S; Montironi R; McCarthy RP; MacLennan GT; Lopez-Beltran A; Jiang Z; Zhou H; Zheng S; Davidson DD; Baldridge LA; Cheng L Prostate; 2008 Jun; 68(9):919-23. PubMed ID: 18409189 [TBL] [Abstract][Full Text] [Related]
34. Vasoactive intestinal peptide (VIP) stimulates in vitro growth of VIP-1 receptor-bearing human pancreatic adenocarcinoma-derived cells. Jiang S; Kopras E; McMichael M; Bell RH; Ulrich CD Cancer Res; 1997 Apr; 57(8):1475-80. PubMed ID: 9108448 [TBL] [Abstract][Full Text] [Related]
36. Changing pattern of expression of the epidermal growth factor receptor and transforming growth factor alpha in the progression of prostatic neoplasms. Scher HI; Sarkis A; Reuter V; Cohen D; Netto G; Petrylak D; Lianes P; Fuks Z; Mendelsohn J; Cordon-Cardo C Clin Cancer Res; 1995 May; 1(5):545-50. PubMed ID: 9816014 [TBL] [Abstract][Full Text] [Related]
37. Estrogen receptor-negative and human epidermal growth factor receptor 2-negative breast cancer tissue have the highest Ki-67 labeling index and EGFR expression: gene amplification does not contribute to EGFR expression. Umemura S; Takekoshi S; Suzuki Y; Saitoh Y; Tokuda Y; Osamura RY Oncol Rep; 2005 Aug; 14(2):337-43. PubMed ID: 16012712 [TBL] [Abstract][Full Text] [Related]